Brevan Howard Capital Management LP Tyra Biosciences, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 46,371 shares of TYRA stock, worth $458,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,371Holding current value
$458,145% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.6MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$105 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$40.9 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$40.3 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$40.1 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$40.1 Million8.77% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $415M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...